Taejon-si, South Korea

Dong-Ha Lee


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Dong-Ha Lee

Introduction

Dong-Ha Lee is a prominent inventor based in Taejon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on benzopyran derivatives. His research focuses on developing compounds that can protect neuronal cells and mitigate brain damage.

Latest Patents

Dong-Ha Lee holds a patent for "Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them." This invention relates to the preparation of benzopyran derivatives that can be utilized for various medical applications, including antioxidation, inhibiting nitric oxide generation, and protecting vital organs during major cardiovascular surgeries.

Career Highlights

Throughout his career, Dong-Ha Lee has been associated with Dongbu Hannong Chemical Co., Ltd., where he has contributed to the development of innovative chemical solutions. His work has been instrumental in advancing pharmaceutical compositions that have the potential to improve patient outcomes.

Collaborations

Dong-Ha Lee has collaborated with notable colleagues, including Hong Seok Lim and Sun-Ok Kim. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Dong-Ha Lee's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to have a significant impact on the protection of neuronal cells and the development of effective treatments for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…